Interleukin 1β increases arginine accumulation and activates the citrulline-NO cycle in rat pancreatic β cells

被引:17
作者
Flodström, M
Chen, MC
Smismans, A
Schuit, F
Pipeleers, DG
Eizirik, DL
机构
[1] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden
[2] Free Univ Brussels, Diabet Res Ctr, Brussels, Belgium
关键词
beta cell; arginine; argininosuccinate synthetase; interleukin; 1; nitric oxide;
D O I
10.1006/cyto.1998.0446
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nitric oxide (NO) may contribute to pancreatic beta cell damage during the development of type 1 diabetes;lts formation can be triggered by cytokines which induce the expression of the inducible form of nitric oxide synthase (iNOS) in pancreatic islets, In the iNOS-catalyzed reaction, arginine is converted into citrulline and NO, Cellular NO formation may be regulated by the availability of arginine, Arginine can be provided extracellularly, entering the cell mainly through the cationic amino acid transporter system y(+)CAT, and intracellularly, by protein degradation or synthesis from citrulline (the citrulline-NO cycle). This study demonstrates for the first time that the citrulline-NO cycle is induced in FAGS-purified rat beta cells exposed to interlenkin-1 beta (IL-1 beta) and that extracellular arginine or citrulline is required for NO production by beta cells, Moreover, the accumulation of arginine was higher in IL-1 beta-treated beta cells than in control cells, beta cells expressed mRNAs for the two y+CAT transporters CAT-2A and CAT-2B with no change in transporter expression after exposure to IL-1 beta, It is concluded that the activation of the citrulline-NO cycle and an increase in arginine accumulation may be adaptive responses in cytokine-exposed beta-cells to assure an adequate arginine supply for continuous NO production in the presence of low extracellular arginine levels which may prevail during insulitis. (C)1999 Academic Press.
引用
收藏
页码:400 / 407
页数:8
相关论文
共 41 条
[1]  
BANNAI S, 1980, J BIOL CHEM, V255, P2372
[2]  
BONNERWEIR S, 1991, ENDOCRINE PANCREAS, V1, P15
[3]  
Closs EI, 1996, AMINO ACIDS, V11, P193, DOI 10.1007/BF00813860
[4]   INTRAISLET RELEASE OF INTERLEUKIN-1 INHIBITS BETA-CELL FUNCTION BY INDUCING BETA-CELL EXPRESSION OF INDUCIBLE NITRIC-OXIDE SYNTHASE [J].
CORBETT, JA ;
MCDANIEL, ML .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (02) :559-568
[5]   TYROSINE KINASE INVOLVEMENT IN IL-1-BETA-INDUCED EXPRESSION OF INOS BY BETA-CELLS PURIFIED FROM ISLETS OF LANGERHANS [J].
CORBETT, JA ;
KWON, G ;
MISKO, TP ;
RODI, CP ;
MCDANIEL, ML .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 267 (01) :C48-C54
[6]   Interleukin-1 beta-mediated inhibition of arginase in RINm5F cells [J].
Cunningham, JM ;
Mabley, JG ;
Green, IC .
CYTOKINE, 1997, 9 (08) :570-576
[7]  
Delaney CA, 1996, BRAZ J MED BIOL RES, V29, P569
[8]   GENOTOXIC AGENTS INCREASE EXPRESSION OF GROWTH ARREST AND DNA DAMAGE - INDUCIBLE GENES GADD 153 AND GADD 45 IN RAT PANCREATIC-ISLETS [J].
EIZIRIK, DL ;
BJORKLUND, A ;
CAGLIERO, E .
DIABETES, 1993, 42 (05) :738-745
[9]  
Eizirik DL, 1996, DIABETOLOGIA, V39, P875
[10]   Role of the citrulline-nitric oxide cycle in the functional response of adult human and rodent pancreatic islets to cytokines [J].
Flodstrom, M ;
Morris, SM ;
Eizirik, DL .
CYTOKINE, 1996, 8 (08) :642-650